Home News Agricultural Invest in Medicinal Cannabis | Grow BioTech

Invest in Medicinal Cannabis | Grow BioTech


One of the Strongest Enterprise Investment Scheme Offers You’ll See in 2018

About Us

Grow BioTech are a cannabis biotech company with a uniquely global and nimble approach to cannabis science. This means constantly assessing the global-cannabis commercial and scientific landscape and only deploying their research capabilities to address the most exciting opportunities with the greatest scientific, medical and commercial potential.

Why Invest?

Grow Biotech P.L.C allows you to access a unique market which is completely new to the UK. The market dynamics appear extremely favourable and the target return is attractive. Grow Biotech is focused on creating game-changing Intellectual Property in the fastest growing industry in the world, Medical Cannabis.

GrowBiotech is Enterprise Investment Scheme (EIS) Eligible.

EIS is a series of UK income and capital gains tax reliefs. The tax relief is intended to offer some compensation for the high risk associated with investing in companies not listed on the stock exchange.

Our Partners

Why Invest in Medical Cannabis?

  • Widely thought to be the fastest growing industry in the world
  • Legal cannabis forecast to grow from a $20bn global industry to $100bn by 2020
  • The European Legal Cannabis Market alone is estimated to be a €56 billion opportunity
  • The list of potential uses and medical treatments is very broad but the scientific work still needs to be done
  • Big Pharma are largely staying out of the legal cannabis which creates a huge opportunity for cannabis specific biotech companies

Why Invest in Grow BioTech?

  • Aiming to Develop one of the World’s Most Valuable portfolios of Cannabis-Intellectual Property Assets by 2022
  • Huge Network Within the Cannabis, Biotech and Medical Communities
  • Approved Under the Enterprise Investment Scheme (EIS)
  • Fast Evolving Business Sector
  • Projected High Returns
  • Diversification of Risk

Call Ross Kelly on 0208 611 2614 or Complete the Form to Download the Brochure

  • Select Category of Investor
    Disclaimer: This investment offering has not been approved by a 'authorised person' under Section 21 of the Financial Services and Markets Act 2000. To view the content, you must be either: (a) High Net Worth Individual A high net worth individual is one who: Had, during the financial year immediately preceding the date of the certificate, an annual income of £100,000 or more. Held, throughout the same year, net assets of £250,000 or more excluding the residential home, a pension or the proceeds of life assurance contracts. or (b) Self-Certified Sophisticated Investor A sophisticated investor is someone who meets at least one of the following criteria: Has been a member of a network or syndicate of business angels for at least the six months preceding the date of the certificate. Has made more than one investment in an unlisted company in the two years preceding that date. Has worked, in the two years preceding that date, in a professional capacity in the private equity sector, or in the provision of finance for small and medium enterprises. Has been, in the two years preceding that date, a director of a company with an annual turnover of at least £1 million. If you do not meet these criteria, you must not take any further action. This website assumes you have a clear understanding of investments of this type and is provided to prospective investors to evaluate the investment being offered. Before you will be able to view the offering you must certify your investor status. Investments of this type carry significant risks and the capital you have invested will be at risk. This investment is not covered by the FSCS.

How useful was this post?

Click on a star to rate it!

Average rating 4 / 5. Vote count: 2

No votes so far! Be the first to rate this post.



Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.